Literature DB >> 20008289

Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.

Aninda Basu1, Andre Hoerning, Dipak Datta, Monika Edelbauer, Maria P Stack, Katiana Calzadilla, Soumitro Pal, David M Briscoe.   

Abstract

In this study, we find that CD45RO+ memory populations of CD4+ T lymphocytes express the vascular endothelial growth factor (VEGF) receptors KDR and Flt-1 at both the mRNA and protein levels. Furthermore, by Western blot analysis, we find that VEGF increases the phosphorylation and activation of ERK and Akt within CD4+CD45RO+ T cells. These VEGF-mediated signaling responses were inhibited by a KDR-specific small interfering RNA in a VEGF receptor-expressing Jurkat T cell line and by SU5416, a pharmacological KDR inhibitor, in CD4+CD45RO+ T cells. We also find that VEGF augments mitogen-induced production of IFN-gamma in a dose-dependent manner (p < 0.001) and significantly (p < 0.05) increases directed chemotaxis of this T cell subset. Collectively, our results for the first time define a novel function for VEGF and KDR in CD45RO+ memory T cell responses that are likely of great pathophysiological importance in immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008289      PMCID: PMC3495980          DOI: 10.4049/jimmunol.0900397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways.

Authors:  H Zeng; H F Dvorak; D Mukhopadhyay
Journal:  J Biol Chem       Date:  2001-05-11       Impact factor: 5.157

2.  Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.

Authors:  S Dias; K Hattori; Z Zhu; B Heissig; M Choy; W Lane; Y Wu; A Chadburn; E Hyjek; M Gill; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity.

Authors:  Hideaki Watanabe; Adam J Mamelak; Binghe Wang; Brandon G Howell; Irwin Freed; Clemens Esche; Masashi Nakayama; Go Nagasaki; Daniel J Hicklin; Robert S Kerbel; Daniel N Sauder
Journal:  Exp Dermatol       Date:  2004-11       Impact factor: 3.960

4.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response.

Authors:  Rafaèle Tordjman; Yves Lepelletier; Valérie Lemarchandel; Marie Cambot; Philippe Gaulard; Olivier Hermine; Paul-Henri Roméo
Journal:  Nat Immunol       Date:  2002-04-15       Impact factor: 25.606

5.  Regulation of Raf-Akt Cross-talk.

Authors:  Karin Moelling; Karen Schad; Magnus Bosse; Sven Zimmermann; Marc Schweneker
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

6.  Proinflammatory functions of vascular endothelial growth factor in alloimmunity.

Authors:  Marlies E J Reinders; Masayuki Sho; Atsushi Izawa; Ping Wang; Debabrata Mukhopadhyay; Kerith E Koss; Christopher S Geehan; Andrew D Luster; Mohamed H Sayegh; David M Briscoe
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung.

Authors:  Chun Geun Lee; Holger Link; Peter Baluk; Robert J Homer; Svetlana Chapoval; Vineet Bhandari; Min Jong Kang; Lauren Cohn; Yoon Keun Kim; Donald M McDonald; Jack A Elias
Journal:  Nat Med       Date:  2004-09-19       Impact factor: 53.440

Review 8.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

9.  Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization.

Authors:  Felix Mor; Francisco J Quintana; Irun R Cohen
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

Review 10.  Angiogenesis in the pathogenesis of inflammatory joint and lung diseases.

Authors:  D A Walsh; C I Pearson
Journal:  Arthritis Res       Date:  2001-02-23
View more
  36 in total

1.  Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.

Authors:  Monika Edelbauer; Dipak Datta; Ingrid H C Vos; Aninda Basu; Maria P Stack; Marlies E J Reinders; Masayuki Sho; Katiana Calzadilla; Peter Ganz; David M Briscoe
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.

Authors:  Jiasheng Zhang; Mahmoud Razavian; Sina Tavakoli; Lei Nie; George Tellides; Joseph M Backer; Marina V Backer; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

3.  Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.

Authors:  Tory P Johnson; Karan Patel; Kory R Johnson; Dragan Maric; Peter A Calabresi; Rodrigo Hasbun; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

Review 4.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 5.  Chronic allograft rejection: a fresh look.

Authors:  Johannes Wedel; Sarah Bruneau; Nora Kochupurakkal; Leo Boneschansker; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

6.  Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.

Authors:  David R Boulware; Shulamith C Bonham; David B Meya; Darin L Wiesner; Gregory S Park; Andrew Kambugu; Edward N Janoff; Paul R Bohjanen
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

Review 7.  The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.

Authors:  Johannes Wedel; Hironao Nakayama; Nora M Kochupurakkal; Josephine Koch; Michael Klagsbrun; Diane R Bielenberg; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

8.  Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.

Authors:  T Hoeres; M Wilhelm; M Smetak; E Holzmann; G Schulze-Tanzil; J Birkmann
Journal:  Clin Exp Immunol       Date:  2018-01-04       Impact factor: 4.330

Review 9.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

10.  Cervical Cytokines Associated With Chlamydia trachomatis Susceptibility and Protection.

Authors:  Taylor B Poston; De'Ashia E Lee; Toni Darville; Wujuan Zhong; Li Dong; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Gregory D Sempowski; Xiaojing Zheng
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.